Rockwell Medical (NASDAQ:RMTI) Cut to “Hold” at StockNews.com

StockNews.com cut shares of Rockwell Medical (NASDAQ:RMTI) from a buy rating to a hold rating in a research report report published on Thursday morning.

Several other research firms have also recently commented on RMTI. Rodman & Renshaw assumed coverage on shares of Rockwell Medical in a research report on Thursday, November 14th. They set a “buy” rating and a $5.00 target price on the stock. HC Wainwright restated a “buy” rating and set a $9.00 price target on shares of Rockwell Medical in a research note on Wednesday, September 11th. Finally, RODMAN&RENSHAW upgraded shares of Rockwell Medical to a “strong-buy” rating in a research note on Thursday, November 14th.

Rockwell Medical Price Performance

Rockwell Medical stock opened at $2.22 on Thursday. Rockwell Medical has a 52 week low of $1.16 and a 52 week high of $5.15. The company’s 50 day moving average price is $3.56 and its two-hundred day moving average price is $2.63. The company has a quick ratio of 2.00, a current ratio of 2.41 and a debt-to-equity ratio of 0.33. The stock has a market cap of $71.75 million, a P/E ratio of -44.00 and a beta of 1.50.

Institutional Investors Weigh In On Rockwell Medical

Several large investors have recently modified their holdings of the stock. Concurrent Investment Advisors LLC purchased a new position in Rockwell Medical in the 3rd quarter valued at approximately $40,000. Verus Capital Partners LLC purchased a new position in Rockwell Medical in the 3rd quarter valued at approximately $51,000. Barclays PLC purchased a new position in Rockwell Medical in the 3rd quarter valued at approximately $90,000. Beacon Financial Advisory LLC purchased a new position in Rockwell Medical in the 3rd quarter valued at approximately $98,000. Finally, XTX Topco Ltd grew its stake in Rockwell Medical by 45.7% in the 3rd quarter. XTX Topco Ltd now owns 28,455 shares of the company’s stock valued at $113,000 after buying an additional 8,922 shares in the last quarter. Hedge funds and other institutional investors own 23.31% of the company’s stock.

Rockwell Medical Company Profile

Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.